The table below shows IRADIMED CORP's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$83.81M
$73.24M
$65.56M
$53.30M
$41.81M
$31.72M
Cost of revenue
$19.49M
$16.89M
$15.40M
$12.02M
$9.76M
$8.14M
Gross profit
$64.32M
$56.35M
$50.16M
$41.28M
$32.05M
$23.57M
R&D
$2.98M
$2.83M
$2.86M
$2.28M
$1.91M
$1.90M
IRMD annual revenue (10-K history)
IRADIMED CORP reported annual revenue of $83.81M for fiscal year 2025. That is up 14.4% from $73.24M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $32.50M (FY 2016) to $83.81M. Figures come from the company's audited annual reports as filed with the SEC.